Presentations

BioCardia Corporate Presentation 2018 Q3
Alliance for Regenerative Medicine's Annual Cell & Gene Therapy Investor Day Presentation

Events

September 2018
Date: September 24, 2018
Location: San Diego, CA
Event: 2018 Transcatheter Cardiovascular Therapeutics Conference
Title: "The CardiAMP Heart Failure Study: First Results from Unblinded Roll-In Phase"

Date: September 24, 2018
Location: San Diego, CA
Event: 2018 Transcatheter Cardiovascular Therapeutics Conference
Title: "Performance of Helix Transendocardial Biotherapeutic Delivery System after 300 Cases"

October 2018
Date: October 3, 2018
Location: La Jolla, CA
Event: 2018 Cell & Gene Meeting on the Mesa
Title: "Successful Strategies in the Design and Delivery of a Cell/Gene Therapy Clinical Development Program"

Date: October 5, 2018
Location: Houston, TX
Event: 2018 Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine
Title: "The CardiAMP Heart Failure Trial"

November 2018
Date: November 12, 2018
Location: Chicago, IL
Event: American Heart Association Scientific Sessions 2018 Conference
Title: "The CardiAMP Heart Failure Trial: Efficacy Outcomes from Roll-In Phase"



News


Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.